Makers Laboratories is currently trading at its upper circuit limit of Rs. 285.20, up by 13.55 points or 4.99% from its previous closing of Rs. 271.65 on the BSE.
The scrip opened at Rs. 274.85 and has touched a high and low of Rs. 285.20 and Rs. 266.00 respectively. So far 20098 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 325.00 on 01-Jan-2021 and a 52 week low of Rs. 23.20 on 24-Mar-2020.
Last one week high and low of the scrip stood at Rs. 285.20 and Rs. 253.70 respectively. The current market cap of the company is Rs. 140.23 crore.
The promoters holding in the company stood at 58.37% and Non-Institutions held 41.63%.
Makers Laboratories’ new ophthalmic/eye drops manufacturing facility at GIDC, Naroda, Ahmedabad in the State of Gujarat, set up at a capital outlay of about Rs 15 crore, has dispatched its first commercial consignment after completing all the necessary qualifications and validations of the manufacturing facility and the product(s).
Makers Laboratories is engaged in manufacturing pharmaceutical formulations and drug intermediaries. The product portfolio of the company includes Tablets & Capsules,Liquids (Oral),Injectables,Drugs (Intermediates)and Creams & Ointments.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1478.35 |
Dr. Reddys Lab | 6009.45 |
Cipla | 1491.00 |
Zydus Lifesciences | 1046.55 |
Lupin | 1601.30 |
View more.. |